NCT06688578 Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait
| NCT ID | NCT06688578 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Massachusetts Eye and Ear Infirmary |
| Condition | Vestibular Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-09-25 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-09-25 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this intervention study is to determine if a new electronic stimulation device, similar to a TENS can improve balance and make walking easier in older individuals with reduced balance function. The main question aims to answer the following: Can using the device improve walking speed in older individuals? Participants will be asked to perform a number of tasks while wearing the device: Walk for 6 minutes * Stand in place while having balance measured (eyes open and closed) * Stand on a foam block while having balance measured (eyes open and closed) * Sit in a chair that will tilt +/- 20 degrees while wearing goggles that take videos of the participants eyes.
Eligibility Criteria
Inclusion Criteria Older (ages 60+) and younger (aged 21-59) participants with no significant health history will be recruited from the community. Exclusion Criteria Any person with a self-reported history of: * impaired proprioception * significant eye problems * neuromuscular disease * seizure * stroke * unmedicated diabetes * cardiovascular disease (except controlled hypertension) * renal disease or electrolyte imbalance * orthopedic disorders such as severe neck or back pain * uncontrolled high blood pressure (200/110 or greater) * implanted electronic devices (pacemakers, defibrillators, implanted pumps or stimulator devices, cochlear, etc.) * psychotic medications or current psychotic symptoms * Any other psychiatric condition requiring hospitalization since 1991 * recent history of alcohol or drug abuse within the past 6 months * inability to stand unassisted for 30 seconds or walk unassisted for 6 minutes
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06688578 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Vestibular Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06688578 currently recruiting?
Yes, NCT06688578 is actively recruiting participants. Contact the research team at jserrador@meei.harvard.edu for enrollment information.
Where is the NCT06688578 trial being conducted?
This trial is being conducted at Baltimore, United States, Boston, United States.
Who is sponsoring the NCT06688578 clinical trial?
NCT06688578 is sponsored by Massachusetts Eye and Ear Infirmary. The trial plans to enroll 120 participants.